A Study to Gather Information About Rivaroxaban in Patients in the United Kingdom Who Have Cancer and Thrombosis (OSCAR-UK)

Clinical trial NCT05112666 · COMPLETED

Trial details

NCT number: NCT05112666
Sponsor: Bayer
Status: COMPLETED
Study type: OBSERVATIONAL

Treatment of Venous Thromboembolism in Cancer Patients

Start date: 2021-12-02
Primary completion: 2022-08-26
Enrollment: 2601

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.